Antipsychotic Polypharmacy: Prevalence, Background and Consequences
NCT ID: NCT00541398
Last Updated: 2009-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
222 participants
INTERVENTIONAL
2008-01-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Compliance Project Concerning People With Schizophrenia
NCT00497848
Shared Decision Making for Antipsychotic Medications
NCT05416658
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
NCT00224276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
From register data areas with differences in the prevalence of antipsychotic polypharmacy will be identified. Two high prevalence areas will be randomized to either control or intervention area. In the intervention area an intensive educational intervention consisting of outreach visits with a multifaceted approach will be carried out with the duration of 1 year.
Differences in health staff related factors such as knowledge and attitude towards clinical guidelines will be assessed with a questionnaire before and after the intervention in the intervention area as well as in the low prevalence area at baseline.
Medical records data describing the use of antipsychotic polypharmacy will be collected. With register data health economic issues will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Implementation of guideline
Outreach visits with interactive education for health staff
B
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implementation of guideline
Outreach visits with interactive education for health staff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with schizophrenia (F2\* diagnosis according to ICD-10) taking antipsychotic medication and their health care providers in the specified areas will enter the study:
* The patients will enter with data from their medical record, register data and a few exploring interviews while the health staff will enter with their questionnaire data.
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Board of Health, Denmark
OTHER_GOV
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Center for Neuropsychiatric Schizophrenia Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birte Glenthøj, Professor
Role: STUDY_DIRECTOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CNSR
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0-204-03-9-9
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.